TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/4/23 18:33 | 1/2/23 | ISEE | Iveric Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Simms Christopher Paul | NJ | O | SVP,Chie | M.d | 0 | 0.00 | 0 | 6 | 24 | 32 | D | ||||||||||||||
1/4/23 18:33 | 1/3/23 | ISEE | Iveric Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Simms Christopher Paul | NJ | O | SVP,Chie | S.d | -48 | 20.06 | 0 | -2 | -7 | 32 | D | ||||||||||||||
8/4/22 16:09 | 8/2/22 | ISEE | Iveric Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Simms Christopher Paul | NJ | O | SVP,Chie | M.d | 0 | 0.00 | 0 | 34 | 29 | D | |||||||||||||||
8/4/22 16:09 | 8/3/22 | ISEE | Iveric Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Simms Christopher Paul | NJ | O | SVP,Chie | S.d | -138 | 11.25 | 0 | -12 | -30 | 29 | D | ||||||||||||||
11/22/21 16:02 | 11/18/21 | ISEE | Iveric Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Simms Christopher Paul | NY | O | SVP,Chie | P | 50 | 16.30 | 0 | 3 | 77 | 7 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |